Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1993 2
1994 2
1996 3
1998 1
1999 2
2000 4
2002 2
2003 4
2004 4
2005 5
2006 3
2007 4
2008 2
2009 2
2010 6
2011 5
2012 3
2013 8
2014 6
2015 4
2016 2
2017 3
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

74 results
Results by year
Filters applied: . Clear all
Page 1
Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss.
Zahoor M, Westhrin M, Aass KR, Moen SH, Misund K, Psonka-Antonczyk KM, Giliberto M, Buene G, Sundan A, Waage A, Sponaas AM, Standal T. Zahoor M, et al. Blood Adv. 2017 Dec 13;1(27):2656-2666. doi: 10.1182/bloodadvances.2017010801. eCollection 2017 Dec 26. Blood Adv. 2017. PMID: 29296919 Free PMC article.
Role of interleukin 16 in multiple myeloma.
Atanackovic D, Hildebrandt Y, Templin J, Cao Y, Keller C, Panse J, Meyer S, Reinhard H, Bartels K, Lajmi N, Sezer O, Zander AR, Marx AH, Uhlig R, Zustin J, Bokemeyer C, Kröger N. Atanackovic D, et al. J Natl Cancer Inst. 2012 Jul 3;104(13):1005-20. doi: 10.1093/jnci/djs257. Epub 2012 Jun 28. J Natl Cancer Inst. 2012. PMID: 22745469
Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.
Lin X, Yang L, Wang G, Zi F, Yan H, Guo X, Chen J, Chen Q, Huang X, Li Y, Zhang E, Wu W, Yang Y, He D, He J, Cai Z. Lin X, et al. Oncotarget. 2017 Oct 7;8(54):92841-92854. doi: 10.18632/oncotarget.21611. eCollection 2017 Nov 3. Oncotarget. 2017. PMID: 29190960 Free PMC article.
74 results
Jump to page
Feedback